13Feb
Ahead of the pack: US M&A 2019: Biotech boosts US healthcare M&A in 2019
The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 billion across 645 deals in 2019. This is a decrease of 9 percent by volume, but an increase of 121 percent by value....
By:
White & Case LLP
Related
On August 14, 2019, the National Labor Relations Board issued a decision in the case of Cordúa Resta...
Read More >
El 23 de Octubre de 2019 entró en vigor la NOM-35-STPS de la Secretaría del Trabajo y Previsión Soci...
Read More >
Under the federal Uniformed Services Employment and Reemployment Rights Act (USERRA), employers are ...
Read More >
The American Hospital Association (“AHA”) recently released a report that concludes that hospital ...
Read More >
Dorman v. The Charles Schwab Corp. narrows the options of employees asserting breach of fiduciary du...
Read More >
I have life insurance and it’s an important financial tool to protect your loved ones. I’ve never ...
Read More >